Ac Immune Sa (ACIU) SEC Filing 20-F Annual report for the fiscal year ending Saturday, December 31, 2016

Ac Immune Sa

CIK: 1651625 Ticker: ACIU

View differences made from one year to another to evaluate Ac Immune Sa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ac Immune Sa.


Assess how Ac Immune Sa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ac Immune Sa's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: ACIU
CIK: 1651625
Form Type: 20-F Annual Report
Accession Number: 0000950103-17-002540
Submitted to the SEC: Fri Mar 17 2017 6:31:53 AM EST
Accepted by the SEC: Fri Mar 17 2017
Period: Saturday, December 31, 2016
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: